Schedule 13D ownership disclosure

CNS RESPONSE, INC.

Security class unavailable · CUSIP: 12619C101

Event date: 2014-07-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.1700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950138-14-000535
Form type
SC 13D/A
Filer
Emmaus Life Sciences, Inc.
CIK
CIK 822370
Filed
Jul 08, 2014
Reporting period
Jul 07, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub